J&J CEO: People Will Need COVID Vaccine With Annual Flu Shot for Next Several Years
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
J&J CEO Says People Will Likely Need COVID Vaccine With Annual Flu Shot for Next Several Years as Variants Spread
Johnson & Johnson CEO Alex Gorsky reiterated Wednesday that people will likely need to receive additional doses of the COVID-19 vaccines alongside the annual flu shot for the next “several years.”
People will need to get the COVID booster shots until herd immunity is achieved on a global level and world leaders and scientists are able to limit the spread of highly contagious variants, Gorsky said during The Wall Street Journal’s Tech Health conference.
“We could be looking at this tagging along with the flu shot, likely over the next several years,” he said, referring to the Covid vaccines.
Cleveland Clinic: Already Had COVID? Vaccine Provides No Added Benefit
The Defender reported:
A new preprint study by the Cleveland Clinic found people previously infected with SARS-CoV-2 were less likely to be reinfected than fully vaccinated individuals who never had the virus — suggesting the vaccine is of no benefit to people who already had COVID.
The Cleveland Clinic recently studied the effectiveness of COVID-19 vaccination among people with a history of previous SARS-CoV-2 infection and those without. The purpose of the study was to evaluate the necessity of COVID vaccination in persons previously infected with SARS-CoV-2.
The study, available on medRxiv, provides insight into how the immune system protects the body once a COVID infection is confirmed, the Cleveland Clinic said.
Watch: Fauci Pal Daszak Admits ‘Chinese Colleagues’ Developing ‘Killer’ Coronaviruses
EcoHealth Alliance President Peter Daszak – who collaborated with the Wuhan Institute of Virology on research funded by Dr. Anthony Fauci’s National Institute of Allergy and Infectious Disease — appears to boast about the manipulation of “killer” SARS-like coronaviruses carried out by his “colleagues in China” in a clip unearthed by The National Pulse.
Yale Doctor Tells RFK, Jr. How He Was Attacked by Colleagues Over COVID Treatment Recommendation for High-Risk Patients
The Defender reported:
When Harvey Risch, M.D., Ph.D., published an article in the American Journal of Epidemiology in May 2020 about the safe and effective use of hydroxychloroquine (HCQ) as an early treatment in COVID patients, he was criticized and attacked by some in the medical industry, including some of his own colleagues.
Risch, a professor of epidemiology at Yale School of Public Health, told Children’s Health Defense Chairman Robert F. Kennedy, Jr., on the “RFK Jr The Defender Podcast,” how 20 of his Yale colleagues signed a letter expressing their “grave concern” about Risch and his recommendation for doctors to start treating COVID patients with HCQ.
New Evidence Suggests COVID-19 Vaccines Remain Effective Against Variants
NPR News reported:
The emergence of new and more infectious variants of the coronavirus has raised a troubling question: Will the current crop of COVID-19 vaccine prevent these variants from causing disease?
A study out Wednesday in the journal Nature suggests the answer is yes.
Illinois Coronavirus Updates: Chicago Seeing ‘Exponential Decay,’ Delta Variant Concerns
NBC 5 Chicago reported:
Chicago’s quick drop in coronavirus cases and deaths related to COVID is being called “exponential decay,” according to the city’s top doc.
But while the city is reaching record lows in some metrics, officials are sounding the alarm on a new variant of the virus.
Many Johnson & Johnson COVID Vaccine Doses May Be Close to Expiring
NBC News reported:
As demand for COVID-19 vaccines declines across the country, unused Johnson & Johnson vaccine doses are piling up on state shelves, leaving state officials increasingly concerned that the lack of a coordinated federal plan to redistribute them means hundreds of thousands, if not millions, of doses will go to waste.
The buildup of doses is largely a result of the Food and Drug Administration’s order in early April pausing distribution of the Johnson & Johnson vaccine because of safety concerns. Enthusiasm for the one-dose shot was dampened after the 11-day pause, according to state officials.